These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32590508)

  • 41. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.
    Lund K; Kito H; Skydtsgaard MB; Nakazawa H; Ohashi-Doi K; Lawton S
    Clin Ther; 2019 Apr; 41(4):742-753. PubMed ID: 30885398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sublingual immunotherapy: current concepts for the U.S. practitioner.
    Lin SY
    Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S55-9. PubMed ID: 25182357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety profile of sublingual immunotherapy.
    Passalacqua G; Guerra L; Fumagalli F; Canonica GW
    Treat Respir Med; 2006; 5(4):225-34. PubMed ID: 16808542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunotherapy in all aspects.
    Hanci D; Şahin E; Muluk NB; Cingi C
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1347-55. PubMed ID: 25673026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure.
    Hennekens CH; Kowalczykowski M; Hollar D
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):149-52. PubMed ID: 16891293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations.
    Leatherman BD; Khalid A; Lee S; McMains K; Peltier J; Platt MP; Stachler RJ; Toskala E; Tropper G; Venkatraman G; Lin SY
    Int Forum Allergy Rhinol; 2015 Sep; 5(9):773-83. PubMed ID: 26097218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature.
    Bots SH; Groepenhoff F; Eikendal ALM; Tannenbaum C; Rochon PA; Regitz-Zagrosek V; Miller VM; Day D; Asselbergs FW; den Ruijter HM
    JACC Heart Fail; 2019 Mar; 7(3):258-266. PubMed ID: 30819382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trials.
    Kaur A; Skoner D; Ibrahim J; Li Q; Lockey RF; Blaiss M; Bufe A; Andersen JS; Canonica GW; Nolte H
    J Allergy Clin Immunol; 2018 May; 141(5):1744-1749. PubMed ID: 29221713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Major allergen content consistency of SQ house dust mite sublingual immunotherapy tablets and relevance across geographic regions.
    Nolte H; Plunkett G; Grosch K; Larsen JN; Lund K; Bollen M
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):298-303. PubMed ID: 27613464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Applications of Sublingual Immunotherapy.
    Edwards TS; Wise SK
    Otolaryngol Clin North Am; 2017 Dec; 50(6):1121-1134. PubMed ID: 29103453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
    Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
    Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sublingual Immunotherapy for the Polyallergic Patient.
    Pepper AN; Calderón MA; Casale TB
    J Allergy Clin Immunol Pract; 2017; 5(1):41-45. PubMed ID: 27452888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.
    Tao L; Shi B; Shi G; Wan H
    Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arguing the misconceptions in allergen-specific immunotherapy.
    Ridolo E; Montagni M; Bonzano L; Senna G; Incorvaia C
    Immunotherapy; 2014; 6(5):587-95. PubMed ID: 24896627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.
    Shekelle PG; Rich MW; Morton SC; Atkinson CS; Tu W; Maglione M; Rhodes S; Barrett M; Fonarow GC; Greenberg B; Heidenreich PA; Knabel T; Konstam MA; Steimle A; Warner Stevenson L
    J Am Coll Cardiol; 2003 May; 41(9):1529-38. PubMed ID: 12742294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative costs of subcutaneous and sublingual immunotherapy.
    French C; Seiberling K
    Curr Opin Otolaryngol Head Neck Surg; 2015 Jun; 23(3):226-9. PubMed ID: 25943960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.